Managing Glucose Control in GDM Patients on Basal-Bolus Insulin After Betamethasone Injection

Understanding the Impact of Betamethasone on Glucose Levels

The American Diabetes Association recommends initiating intensive blood glucose monitoring with capillary glucose checks every 1-2 hours after betamethasone administration in GDM patients on basal-bolus insulin 1

The American Diabetes Association suggests targeting glucose values: fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, or 2-hour postprandial <120 mg/dL in GDM patients on basal-bolus insulin after betamethasone administration 2, 3
Increase total daily insulin dose by 40-60% during the peak effect period, with emphasis on prandial coverage, as recommended by clinical guidelines 4
Distribute insulin as 40% basal and 60% prandial to address postprandial hyperglycemia in GDM patients on basal-bolus insulin after betamethasone administration 4
For patients on subcutaneous insulin, consider increasing both basal and bolus components: increase basal insulin by 20-30% and increase prandial insulin by 30-50% based on pre-meal glucose readings 4
Adjust insulin doses downward by 10-20% if glucose readings normalize, as recommended by clinical guidelines 4

Use point-of-care glucose testing that meets accuracy standards for professional use in hospital settings, as recommended by the American Diabetes Association 5
Consider ketone monitoring (urine or blood) in patients with unexplained hyperglycemia or symptoms of ketosis, as recommended by the American Diabetes Association 5